Latest total liabilities for ESALF: $450B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2022), ESALF shows a total liabilities of $450B. That compares with $410B in the prior-year period — up 11.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ESALF's total liabilities is now $450B (was $410B) — a 11.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Eisai , Ltd. is outperforming or lagging.
Tracking ESALF's total liabilities over time shows whether Eisai , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $450B That compares with $410B in the prior-year period — up 11.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Eisai , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $450B) with ownership activity and broader fundamentals.
Eisai , Ltd.'s total liabilities is $450B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.